Literature DB >> 17458537

Intensive insulin therapy in the ICU: benefit versus harm?

F M Brunkhorst1, K Reinhart2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17458537     DOI： 10.1007/s00134-007-0648-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Intensive insulin therapy in the medical ICU.

Authors:  Greet Van den Berghe; Alexander Wilmer; Greet Hermans; Wouter Meersseman; Pieter J Wouters; Ilse Milants; Eric Van Wijngaerden; Herman Bobbaers; Roger Bouillon
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

3.  Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.

Authors:  Greet Van den Berghe; Alexander Wilmer; Ilse Milants; Pieter J Wouters; Bernard Bouckaert; Frans Bruyninckx; Roger Bouillon; Miet Schetz
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461
  3 in total
  2 in total

1.  Strict versus moderate glucose control after resuscitation from ventricular fibrillation.

Authors:  Tuomas Oksanen; Markus B Skrifvars; Tero Varpula; Anne Kuitunen; Ville Pettilä; Jouni Nurmi; Maaret Castrén
Journal:  Intensive Care Med       Date:  2007-10-11       Impact factor: 17.440

2.  Untangling glycaemia and mortality in critical care.

Authors:  Vincent Uyttendaele; Jennifer L Dickson; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  Crit Care       Date:  2017-06-24       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.